This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
“compound 60b” (Taisho D486N mutant RSV fusion protein inhibitor clinical candidate)
molecule
2 years ago ●
1 min read
“compound 15a” (Novartis reversible in vivo ATX inhibitor)
molecule
2 years ago ●
1 min read
“compound 31” (Merck cholesteryl ester transfer protein (CETP) inhibitor)
molecule
2 years ago ●
1 min read
“compound 36” (GlaxoSmithKline (GSK) oral TRPV4 ion channel antagonist backup)
molecule
2 years ago ●
1 min read
BCPyr (Pfizer cIAP1-based BTK degrader)
molecule
2 years ago ●
1 min read
“compound 4j” (Janssen (JNJ) brain-penetrant in vivo 5-HT2 antagonist and 5-HT7 inverse agonist, backup candidate)
molecule
2 years ago ●
1 min read
Load More